Try our beta test site
3065 studies found for:    Open Studies | "Endocrine System Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Condition: Endocrine Diseases
Intervention:
2 Recruiting Salivary Cortisol Measurements by Mass Spectrometry
Condition: Endocrine Disorders
Intervention:
3 Recruiting Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Condition: Endocrine Disease
Interventions: Other: Data Collection;   Behavioral: Follow Up
4 Recruiting Tissue Samples and Bodily Fluid Specimens Banking
Condition: Endocrine Disorders of Female Reproductive System
Intervention: Procedure: collect body fluids/tissues & med history
5 Recruiting Characteristics of Women With Reproductive Concerns
Condition: Endocrine Disorders of Female Reproductive System
Intervention:
6 Recruiting Cardiac Steatosis in Cushing's Syndrome
Conditions: Endocrine System Disease;   Cardiovascular Imaging
Intervention: Other: 1H magnetic resonance spectroscopy and CMRI
7 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
8 Recruiting Evaluation of Women With Endocrine and Reproductive-Related Conditions
Conditions: Endocrine Disease;   Infertility
Intervention:
9 Recruiting Preservation of Ovarian Tissue and Chemo-Radiotherapy
Conditions: Endocrine Disorders of Female Reproductive System;   Secondary Infertility;   Infertility Involuntary
Intervention: Procedure: surgery
10 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Conditions: XXY (Klinefelter);   Sex Chromosome Variation;   Sex Chromosome Aneuploidy;   XXXY;   XXXXXY;   XYY (Jacob);   XXYY;   X (XO, Turner);   XXX (Trisomy X, Triple X);   XXXX (Tetrasomy X);   XXXXX (Pentasomy X)
Intervention:
11 Recruiting A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Conditions: Growth Hormone Deficiency, Pediatric;   hGH (Human Growth Hormone);   Endocrine System Diseases;   Hormones;   Pituitary Diseases
Interventions: Drug: Once weekly subcutaneous injection of TransCon hGH;   Drug: Once daily subcutaneous injection of Genotropin
12 Not yet recruiting Dynamic Hormone Diagnostics in Endocrine Disease
Conditions: Adrenal Insufficiency;   Congenital Adrenal Hyperplasia;   Cushing Syndrome;   Growth Hormone Deficiency;   Acromegaly;   Primary Hyperaldosteronism
Intervention: Other: 27 hour subcutaneous fluid sampling
13 Recruiting Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique
Conditions: Diabetes Mellitus;   Insulin Resistance;   Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases
Interventions: Drug: 6-DIG;   Procedure: clamp
14 Recruiting Hormonal Regulation of Puberty and Fertility
Conditions: Endocrine Disease;   Infertility;   Hypogonadism;   Amenorrhea;   Adolescents
Intervention:
15 Not yet recruiting Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
Conditions: IGHD - Isolated Growth Hormone Deficiency;   Growth Retardation
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo
16 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
17 Recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
18 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
19 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
20 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.